Skip to main content
. 1999 Jan;6(1):79–84. doi: 10.1128/cdli.6.1.79-84.1999

TABLE 1.

Disease stage and hematologic characteristics of patients with CTCL

Patient Type CTCL Stagea WBC/μlb Sezary cells in blood
% Cells/μl
1 MF Ia 4,800 0 0
2 MF Ia 4,200 0 0
3 MF Ib 8,300 0 0
4 MF Ib 5,100 5 255
5 MF IIa 7,200 28 2,016
6 MF IIb 3,500 0 0
7 MF IIb 3,500 0 0
8 MF IIb 4,300 5 215
9 MF III 5,000 16 800
10 MF III 4,800 0 0
11 MF IVa 4,000 0 0
12 MF IVa 2,600 20 520
13 SS III 4,400 28 1,232
14 SS III 5,600 17 952
15 SS III 10,700 9 963
16 SS III 5,500 28 1,540
17 SS III 7,900 20 1,580
18 SS III 4,800 35 1,680
19 SS III 2,500 14 350
20 SS IVa 5,300 24 1,272
21 SS IVa 6,800 11 748
22 SS IVa 11,300 2 226
23 SS IVa 10,000 11 1,100
24 SS IVa 9,900 16 1,584
25 SS IVa 6,300 32 2,016
a

All patients had a complete physical examination and staging workup, including a blood smear for Sezary cells and skin biopsy for histology. 

b

WBC, leukocytes.